Xu X - Search Results

1

Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in China.

Zhang Z, Lei J, Shao X, Dong F, Wang J, Wang D, Wu S, Xie W, Wan J, Chen H, Ji Y, Yi Q, Xu X, Yang Y, Zhai Z, Wang C; China Venous Thromboembolism Study Group. Zhang Z, et al. Among authors: xu x. Chest. 2019 Feb;155(2):342-353. doi: 10.1016/j.chest.2018.10.040. Epub 2018 Nov 9. Chest. 2019. PMID: 30419233

2

Hypertension control in community health centers across China: analysis of antihypertensive drug treatment patterns.

Wang Z, Wang X, Chen Z, Wang W, Zhu H, Chen W, Zhu M, Hu S, Staessen JA, Liu L, Fodor JG; Hypertension Control in Community Health Center Project Group. Wang Z, et al. Am J Hypertens. 2014 Feb;27(2):252-9. doi: 10.1093/ajh/hpt186. Epub 2013 Oct 9. Am J Hypertens. 2014. PMID: 24108862

3

Prevalence, Awareness, and Treatment of Isolated Diastolic Hypertension: Insights From the China PEACE Million Persons Project.

Mahajan S, Zhang D, He S, Lu Y, Gupta A, Spatz ES, Lu J, Huang C, Herrin J, Liu S, Yang J, Wu C, Cui J, Zhang Q, Li X, Nasir K, Zheng X, Krumholz HM, Li J; China PEACE Collaborative Group §; China PEACE Collaborative Group<xref ref-type="author-note" rid="jah34457-note-1004"><sup>§</sup></xref>. Mahajan S, et al. J Am Heart Assoc. 2019 Oct;8(19):e012954. doi: 10.1161/JAHA.119.012954. Epub 2019 Sep 28. J Am Heart Assoc. 2019. PMID: 31566101 Free PMC article.

4

Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension.

Hu X, Yuan P, Chen J, Wang S, Zhao H, Wei Y, Fu J, Chen F, Ruan H, Zhang W, Zhou Y, Wang Q, Xu X, Feng K, Guo J, Gong S, Zhang R, Zhao Q, Wang L. Hu X, et al. Among authors: xu x. Clin Cardiol. 2024 Feb;47(2):e24245. doi: 10.1002/clc.24245. Clin Cardiol. 2024. PMID: 38402556 Free PMC article.

5

Evaluating the efficacy and safety of oral triple sequential combination therapy for treating patients with pulmonary arterial hypertension: A multicenter retrospective study.

Zhao QH, Chen J, Chen FD, Ruan HY, Zhang W, Zhou YL, Wang QQ, Xu XL, Feng KF, Guo JZ, Gong SG, Zhang RF, Wang L. Zhao QH, et al. Pulm Circ. 2024 Mar 10;14(1):e12351. doi: 10.1002/pul2.12351. eCollection 2024 Jan. Pulm Circ. 2024. PMID: 38468630 Free PMC article.

6

Aluminium-doped Carbon Dots for the Simultaneous Selective Detection of Five Tetracycline Antibiotics.

Yu C, Sun Q, Wang Z, Sun M, Xu X, Li W. Yu C, et al. Among authors: xu x. J Fluoresc. 2024 May 8. doi: 10.1007/s10895-024-03738-1. Online ahead of print. J Fluoresc. 2024. PMID: 38717649

7

An extensive analysis of the prognostic and immune role of FOXO1 in various types of cancer.

Li J, Wang C, Xu X, Chen J, Guo H. Li J, et al. Among authors: xu x. Braz J Med Biol Res. 2024 May 3;57:e13378. doi: 10.1590/1414-431X2024e13378. eCollection 2024. Braz J Med Biol Res. 2024. PMID: 38716982

8

LEOPARD Syndrome.

Lin Y, Xu X. Lin Y, et al. Among authors: xu x. Int J Dermatol. 2024 May 8. doi: 10.1111/ijd.17219. Online ahead of print. Int J Dermatol. 2024. PMID: 38716686 No abstract available.

9

Natural tea polyphenol functionalized graphene anode for simultaneous power production and degradation of methyl orange dye in microbial fuel cells.

Guo D, Fu Q, Wang X, Li L, Xu X, An X. Guo D, et al. Among authors: xu x. RSC Adv. 2024 May 7;14(21):14847-14856. doi: 10.1039/d4ra00613e. eCollection 2024 May 2. RSC Adv. 2024. PMID: 38716101 Free PMC article.

10

Identification of Key Genes and Pathways in Oxaliplatin-Induced Neuropathic Pain Through Bioinformatic Analysis.

Lou Y, Xu X, Wang R, Yao D. Lou Y, et al. Among authors: xu x. J Pain Res. 2024 May 3;17:1639-1650. doi: 10.2147/JPR.S452594. eCollection 2024. J Pain Res. 2024. PMID: 38716040 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53,689 results

Search Page